Neuraxis, Inc. (NRXS) vs Rallybio Corporation (RLYB)
- Neuraxis, Inc. NRXS 6.05 −11.81%
- Rallybio Corporation RLYB 15.74 −1.01%
Neuraxis, Inc. and Rallybio Corporation are both Biotechnology companies. Neuraxis, Inc. and Rallybio Corporation are of similar size ($86.2M and $85.6M). Neuraxis, Inc. has negative trailing earnings, so its P/E is not meaningful; Rallybio Corporation trades at 3.3×. Neuraxis, Inc. grew revenue faster over the last twelve months: 65.2% against 1.18%. Rallybio Corporation has the higher net margin (0.00% vs −159.0%) and the lower return on invested capital (−944.4% vs 0.00%). Across the 16 metrics below, Rallybio Corporation leads on 12 and Neuraxis, Inc. on 4.
Valuation
Profitability
| Metric | NRXS | RLYB | Biotechnology median |
|---|---|---|---|
| Gross margin | 85.56% | 100.00% | 65.16% |
| Operating margin | (144.51%) | 0.00% | 0.00% |
| Net margin | (159.01%) | 0.00% | 0.00% |
| Free cash flow margin | (106.10%) | 0.00% | 0.00% |
| Return on equity | (153.96%) | 34.52% | (50.12%) |
| Return on assets | (98.96%) | 32.85% | (45.60%) |
| Return on invested capital | 0.00% | (944.36%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack